drugset / Trial / NCT03388125

Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection

NCT03388125

Phase 3 Unknown 113 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Endoscopic Injection Sclerotherapy vs N-butyl-2-cyanoacrylate Injection

Timeline

Start
2016-01-01
Primary completion
2017-08-01
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-butyl-2-cyanoacrylate Other / unclassified Other
Comparator ethanolamine oleate Small molecule 5 % Other